National Wealth Management Group’s ResMed RMD Stock Holding History

National Wealth Management Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,775	Closed	-$477K	–	154
2023 Q4	$477K	Buy	+2,775	New	+$426K	0.46%	61

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

National Wealth Management Group's RMD Position: Q1 2024 in Review

National Wealth Management Group sold out of ResMed (RMD) in Q1 2024, closing a stake of 2,775 shares — an estimated $477K sold.

National Wealth Management Group first reported a position in RMD in Q4 2023 and held it in 1 quarter. The position peaked at $477K in Q4 2023. 718 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

National Wealth Management Group reported no remaining ResMed position as of Q1 2024 after selling out during the quarter.
National Wealth Management Group sold 2,775 ResMed shares in Q1 2024, an estimated $477K.
National Wealth Management Group first reported a position in ResMed in Q4 2023 and held it in 1 quarter.
National Wealth Management Group's ResMed position peaked at $477K in Q4 2023.
718 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on National Wealth Management Group's 13F filing for Q1 2024, filed 17 May 2024.